SK185299A3 - Polymorphs of 8-chloro-6,11-dihydro-11-(4-piperidylidene)-5h- benzo[5,6] cyclohepta[1,2-b]pyridine - Google Patents

Polymorphs of 8-chloro-6,11-dihydro-11-(4-piperidylidene)-5h- benzo[5,6] cyclohepta[1,2-b]pyridine Download PDF

Info

Publication number
SK185299A3
SK185299A3 SK1852-99A SK185299A SK185299A3 SK 185299 A3 SK185299 A3 SK 185299A3 SK 185299 A SK185299 A SK 185299A SK 185299 A3 SK185299 A3 SK 185299A3
Authority
SK
Slovakia
Prior art keywords
polymorphic form
vwd
descarbonylethoxyloratadine
characteristic peaks
crystalline
Prior art date
Application number
SK1852-99A
Other languages
English (en)
Slovak (sk)
Inventor
Doris P Schumacher
Junning Lee
Lawrence R Rogers
Charles G Eckhart
Naneshwar S Sawant
Michael B Mitchell
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25389724&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK185299(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of SK185299A3 publication Critical patent/SK185299A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK1852-99A 1997-07-02 1998-07-01 Polymorphs of 8-chloro-6,11-dihydro-11-(4-piperidylidene)-5h- benzo[5,6] cyclohepta[1,2-b]pyridine SK185299A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88676697A 1997-07-02 1997-07-02
PCT/US1998/013433 WO1999001450A1 (en) 1997-07-02 1998-07-01 POLYMORPHS OF 8-CHLORO-6, 11-DIHYDRO-11- (4-PIPERIDYLIDENE) -5H-BENZO[5,6] CYCLOHEPTA[1,2-b]PYRIDINE

Publications (1)

Publication Number Publication Date
SK185299A3 true SK185299A3 (en) 2000-07-11

Family

ID=25389724

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1852-99A SK185299A3 (en) 1997-07-02 1998-07-01 Polymorphs of 8-chloro-6,11-dihydro-11-(4-piperidylidene)-5h- benzo[5,6] cyclohepta[1,2-b]pyridine

Country Status (26)

Country Link
EP (1) EP0993455B1 (ja)
JP (2) JP2002507991A (ja)
KR (1) KR20010014316A (ja)
CN (1) CN1261886A (ja)
AR (1) AR013161A1 (ja)
AT (1) ATE239010T1 (ja)
AU (1) AU734487B2 (ja)
BR (1) BR9811658A (ja)
CA (1) CA2294352C (ja)
CO (1) CO4940423A1 (ja)
DE (1) DE69814076T2 (ja)
ES (1) ES2197480T3 (ja)
HK (1) HK1024687A1 (ja)
HU (1) HUP0004308A3 (ja)
IL (1) IL133387A (ja)
MY (1) MY132943A (ja)
NO (1) NO996547L (ja)
NZ (1) NZ501417A (ja)
PE (1) PE86399A1 (ja)
PL (1) PL337712A1 (ja)
RU (1) RU2197485C2 (ja)
SK (1) SK185299A3 (ja)
TR (1) TR199903308T2 (ja)
UA (1) UA62976C2 (ja)
WO (1) WO1999001450A1 (ja)
ZA (1) ZA985783B (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7405223B2 (en) 2000-02-03 2008-07-29 Schering Corporation Treating allergic and inflammatory conditions
US7678908B2 (en) * 2002-04-15 2010-03-16 Sun Pharmaceutical Industries Limited Process of preparing desaloratadine
JP2005539010A (ja) 2002-08-05 2005-12-22 サンド・アクチエンゲゼルシヤフト デスロラタジンヘミフマレートの新規な塩及び多形体
DE602004004453T2 (de) * 2003-03-12 2007-11-08 Teva Pharmaceutical Industries Ltd. Stabile pharmazeutische zusammensetzungen mit desloratadin
US20060135547A1 (en) * 2003-03-12 2006-06-22 Toth Zoltan G Stable pharmaceutical compositions of desloratadine and processes for preparation of polymorphic forms of desloratadine
EA011894B1 (ru) * 2004-07-07 2009-06-30 Эгиш Дьёдьсердьяр Нирт. Новая псевдополиморфная форма деслоратадина, образованная с диоксидом углерода
CA2641668A1 (en) * 2005-11-17 2008-05-15 Teva Pharmaceutical Industries Ltd. Desloratadine crystalline forms mixtures having a low level of residual solvents
HU230417B1 (hu) * 2006-10-26 2016-05-30 Egis Gyógyszergyár Zrt Eljárás desloratadine szén-dioxiddal képezett adduktjának előállítására
WO2008138563A1 (en) * 2007-05-11 2008-11-20 Ratiopharm Gmbh Pharmaceutical composition comprising desloratadine
EP2269586B1 (en) 2009-07-01 2011-09-21 Alfred E. Tiefenbacher (GmbH & Co. KG) Pharmaceutical composition comprising desloratadine
ES2709487T3 (es) 2010-05-10 2019-04-16 Lesvi Laboratorios Sl Formulaciones farmacéuticas estables que contienen un antihistamínico
EP2727592A1 (en) 2012-11-05 2014-05-07 Kücükgüzel, Sükriye Güniz A combination of desloratadine and paracetamol
CN103755682A (zh) * 2013-12-30 2014-04-30 山东达因海洋生物制药股份有限公司 一种地氯雷他定新晶型及制备方法
CN108358892A (zh) * 2018-04-11 2018-08-03 常州方圆制药有限公司 一种地氯雷他定粗品的提纯方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU570306B2 (en) * 1984-02-15 1988-03-10 Schering Corporation 8-chloro-6, 11-dihydro-11-(4-piperidylidene)-5h-benzo (5,6) cyclohepta (1,2-b) pyridine and its salts.
DE3677842D1 (de) * 1985-05-13 1991-04-11 Schering Corp Verfahren zur herstellung von piperidyliden-dihydrodibenzo(a,d)zykloheptenen und deren azoderivate, so hergestellte verbindungen und ihre anwendung zur vorbereitung von heilmitteln.

Also Published As

Publication number Publication date
TR199903308T2 (xx) 2000-11-21
JP2002507991A (ja) 2002-03-12
AR013161A1 (es) 2000-12-13
IL133387A (en) 2004-02-08
HUP0004308A3 (en) 2004-07-28
KR20010014316A (ko) 2001-02-26
PE86399A1 (es) 1999-10-23
CO4940423A1 (es) 2000-07-24
MY132943A (en) 2007-10-31
NZ501417A (en) 2000-10-27
EP0993455A1 (en) 2000-04-19
CA2294352C (en) 2008-05-06
EP0993455B1 (en) 2003-05-02
CN1261886A (zh) 2000-08-02
PL337712A1 (en) 2000-08-28
AU8271098A (en) 1999-01-25
DE69814076T2 (de) 2004-02-26
BR9811658A (pt) 2000-09-05
ATE239010T1 (de) 2003-05-15
IL133387A0 (en) 2001-04-30
HUP0004308A2 (hu) 2001-10-28
ZA985783B (en) 1999-01-19
NO996547D0 (no) 1999-12-29
JP2009242436A (ja) 2009-10-22
CA2294352A1 (en) 1999-01-14
WO1999001450A1 (en) 1999-01-14
UA62976C2 (en) 2004-01-15
NO996547L (no) 2000-03-01
RU2197485C2 (ru) 2003-01-27
ES2197480T3 (es) 2004-01-01
HK1024687A1 (en) 2000-10-20
DE69814076D1 (de) 2003-06-05
AU734487B2 (en) 2001-06-14

Similar Documents

Publication Publication Date Title
DE69720719T2 (de) Mesylat des trihydrats des 5-(2-(4-(1,2-benzothiazol-3-yl)-1-piperazinyl)ethyl)-6-chlor-1,3-dihydro-2(1h)-indol-2-ons (=ziprasidon), seine herstellung und seine anwendung als dopamin d2 antagonist
EP1660482B1 (de) 3-[(2-{ 4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino] -propionsäure-ethylester -methansulfonat und dessen verwendung als arzneimittel
US6506767B1 (en) 8-chloro-6,11-dihydro-11-(4-piperidylidine)-5H-benzo[5,6]cyclohepta[1-2-b] pyridine
SK185299A3 (en) Polymorphs of 8-chloro-6,11-dihydro-11-(4-piperidylidene)-5h- benzo[5,6] cyclohepta[1,2-b]pyridine
HUE029324T2 (en) Polymorphic forms of an MGLUR5 receptor antagonist
CA2464961A1 (en) Polymorphous forms of rosiglitazone maleate
EP0508334B1 (en) Novel aminophenol derivatives and pharmaceutical compositions thereof
HUT71132A (en) Bis-aryl-carbinol derivatives, pharmaceutical compositions containing them and process for producing
KR19980064286A (ko) 다형태를 갖는 독사조신 메실레이트의 새로운 형태(제 1형)
BE1014454A6 (nl) Amlodipinehemimaleaat.
EP0405342B1 (en) (1,2,3,4-Tetrahydro-9-acridinimino)cyclohexane carboxylic acid and related compounds, a process for their preparation and their use as medicaments
CZ321095A3 (en) Heterocyclic compounds
DE69816456T2 (de) Verwendung von 4-substituierten tetrahydropyridinen zur herstellung eines arzneimittels mit wirkung auf tgf-beta-1
KR19980064287A (ko) 다형태를 갖는 독사조신 메실레이트의 새로운 형태(제 ii 형)
CZ460399A3 (cs) Polymorfy 8-chlor-6,ll-dihydro-ll-(4- piperidy!iden)-5Hbenzo/5,6/cyklohepta/l,2-b/pyridinu
JP2791069B2 (ja) シクロオクタン神経保護剤
JPS6163635A (ja) アシルアントロン誘導体、その製法および用途
RU2330022C2 (ru) НОВАЯ КРИСТАЛЛИЧЕСКАЯ МОДИФИКАЦИЯ 2-(3, 5-БИС-ТРИФТОРМЕТИЛФЕНИЛ)-N-[6-(1, 1-ДИОКСО-1 λ6-ТИОМОРФОЛИН-4-ИЛ)-4-(4-ФТОР-2-МЕТИЛФЕНИЛ)ПИРИДИН-3-ИЛ]-N-МЕТИЛИЗОБУТИРАМИДА
MXPA00000133A (en) POLYMORPHS OF 8-CHLORO-6, 11-DIHYDRO-11- (4-PIPERIDYLIDENE) -5H-BENZO[5,6]CYCLOHEPTA[1, 2-b]PYRIDINE
CA2615842A1 (en) Polymorphs of 8-chloro-6,11-dihydro-11-(4-piperidylidene)-5h-benzo[5,6]cyclohepta[1,2-b]pyridine
NL1018759C1 (nl) Amlodipinehemimaleaat.
JPH0529227B2 (ja)
JPS6229588A (ja) ピラゾロ〔４，３−ｄ〕ピリミジン誘導体
JPH0390086A (ja) ラセミ形のおよび光学的に活性な（＋）―または（―）―エナンチオマー状のデヒドロシクロクラウセンアミドおよびそれの誘導体の製法
CS259646B1 (cs) Způsob přípravy diarylmethyI-4-tetrahydrothiopyranyletherů a Jejich methojodidů